Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Apellis Pharmaceuticals Inc | 1 avril 2019 - |
Executive Vice President - Clinical Development | Apellis Pharmaceuticals Inc | 1 octobre 2017 - 1 avril 2019 |
Vice President - Clinical Development | Apellis Pharmaceuticals Inc | 1 octobre 2014 - 1 octobre 2017 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-01-09 | 2023-01-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.6%
48,79121 975 USD |
2 500 -2.6% | 48,79 | 121 975 USD | |
2022-12-02 | 2022-12-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.5%
49,93124 825 USD |
2 500 -2.5% | 49,93 | 124 825 USD | |
2022-11-03 | 2022-11-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.4%
60,83152 075 USD |
2 500 -2.4% | 60,83 | 152 075 USD | |
2022-09-02 | 2022-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.3%
60,30150 750 USD |
2 500 -2.3% | 60,30 | 150 750 USD | |
2022-08-02 | 2022-08-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.3%
55,99139 975 USD |
2 500 -2.3% | 55,99 | 139 975 USD | |
2022-06-02 | 2022-06-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.2%
41,78104 450 USD |
2 500 -2.2% | 41,78 | 104 450 USD | |
2022-05-03 | 2022-05-02 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 500
-2.2%
43,56108 900 USD |
2 500 -2.2% | 43,56 | 108 900 USD | |
2022-03-17 | 2022-03-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
375
-0.3%
39,5714 839 USD |
375 -0.3% | 39,57 | 14 839 USD | |
2022-02-02 | 2022-02-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
375
-0.4%
40,5815 218 USD |
375 -0.4% | 40,58 | 15 218 USD | |
2022-01-19 | 2022-01-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
375
-0.5%
40,5615 210 USD |
375 -0.5% | 40,56 | 15 210 USD | |
2021-12-17 | 2021-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
375
-0.5%
42,8816 080 USD |
375 -0.5% | 42,88 | 16 080 USD | |
2021-12-03 | 2021-12-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
375
-0.6%
42,4015 900 USD |
375 -0.6% | 42,40 | 15 900 USD | |
2021-11-17 | 2021-11-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
625
-1.0%
43,5027 188 USD |
625 -1.0% | 43,50 | 27 188 USD | |
2021-11-02 | 2021-11-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
625
-1.0%
30,7019 188 USD |
625 -1.0% | 30,70 | 19 188 USD | |
2021-10-15 | 2021-10-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
750
-1.1%
34,5725 928 USD |
750 -1.1% | 34,57 | 25 928 USD | |
2021-10-05 | 2021-10-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
750
-1.1%
33,2624 945 USD |
750 -1.1% | 33,26 | 24 945 USD | |
2021-06-15 | 2021-06-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.9%
61,8430 920 USD |
500 -0.9% | 61,84 | 30 920 USD | |
2021-05-18 | 2021-05-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.9%
45,3922 695 USD |
500 -0.9% | 45,39 | 22 695 USD | |
2021-05-04 | 2021-05-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.1%
50,7330 438 USD |
600 -1.1% | 50,73 | 30 438 USD | |
2021-04-15 | 2021-04-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.9%
42,8221 410 USD |
500 -0.9% | 42,82 | 21 410 USD | |
2021-04-05 | 2021-04-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.0%
43,4126 046 USD |
600 -1.0% | 43,41 | 26 046 USD | |
2021-03-17 | 2021-03-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.9%
46,7723 385 USD |
500 -0.9% | 46,77 | 23 385 USD | |
2021-03-08 | 2021-03-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 000
-8.0%
48,62243 075 USD |
5 000 -8.0% | 48,62 | 243 075 USD | |
2021-03-03 | 2021-03-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.0%
48,5829 148 USD |
600 -1.0% | 48,58 | 29 148 USD | |
2021-02-17 | 2021-02-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.8%
46,0023 000 USD |
500 -0.8% | 46,00 | 23 000 USD | |
2021-02-02 | 2021-02-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.0%
44,0026 400 USD |
600 -1.0% | 44,00 | 26 400 USD | |
2021-01-15 | 2021-01-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
4 000
-10.0%
51,99207 960 USD |
4 000 -10.0% | 51,99 | 207 960 USD | |
2021-01-05 | 2021-01-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.5%
57,2434 344 USD |
600 -1.5% | 57,24 | 34 344 USD | |
2020-12-02 | 2020-12-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-1.8%
48,2528 950 USD |
600 -1.8% | 48,25 | 28 950 USD | |
2020-11-03 | 2020-11-02 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-2.1%
31,0918 654 USD |
600 -2.1% | 31,09 | 18 654 USD | |
2020-10-02 | 2020-10-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-2.1%
30,2218 132 USD |
600 -2.1% | 30,22 | 18 132 USD | |
2020-09-02 | 2020-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-2.0%
31,5818 948 USD |
600 -2.0% | 31,58 | 18 948 USD | |
2020-08-05 | 2020-08-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
600
-2.0%
26,2815 768 USD |
600 -2.0% | 26,28 | 15 768 USD | |
2020-07-02 | 2020-07-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
850
-2.7%
32,4327 566 USD |
850 -2.7% | 32,43 | 27 566 USD | |
2020-06-16 | 2020-06-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
856
-2.7%
30,2125 860 USD |
856 -2.7% | 30,21 | 25 860 USD |